Introduction {#s1}
============

Hypotheses attempting to explain the seasonality of epidemic influenza transmission in temperate regions fall into 3 broad categories: 1) seasonal changes in host behavior, mixing patterns and contact rates [@pone.0020743-Cauchemez1], [@pone.0020743-Cauchemez2]; 2) seasonal changes in host immune function [@pone.0020743-Cannell1], [@pone.0020743-Cannell2]; and 3) seasonal changes of environmental conditions that affect virus survival and transmissibility [@pone.0020743-Shaman1], [@pone.0020743-Shaman2]. These 3 hypotheses are not mutually exclusive, and influenza transmission dynamics are potentially affected in some fashion by all 3 processes.

Here we explore the second effect, the role that seasonal changes of host immune function may have on influenza infection rates. In particular, we focus on the effect of vitamin D, which is converted from 7-dehydrocholesterol in the skin upon absorption of UVB rays from the sun [@pone.0020743-Cannell1]. The resulting product converts to 25-hydroxy-vitamin D~3~ \[25(OH)D\] and subsequently to 1,25-dihydroxy-vitamin D~3~, which in combination with vitamin D receptors triggers innate immune responses [@pone.0020743-Wang1], [@pone.0020743-Liu1] that may be effective against influenza infection [@pone.0020743-Yamshchikov1], [@pone.0020743-Urashima1], particularly at high levels [@pone.0020743-Sabetta1].

An association between vitamin D and likelihood of influenza virus infection was first noted in laboratory experiments with animal models [@pone.0020743-Young1]. A study on prevention of industrial absenteeism also found that cod liver oil rich in vitamin D reduced lost time due to respiratory illness [@pone.0020743-Holmes1]. Since those early findings, a number of investigators have hypothesized that the decreased sunlight levels in temperate regions during winter, which decrease vitamin D concentrations and host immune function, increase susceptibility to influenza infection [@pone.0020743-Cannell2], [@pone.0020743-HopeSimpson1]. Further, observational studies and a placebo-controlled trial also found that higher levels of vitamin D or vitamin D supplementation prevented respiratory tract infections [@pone.0020743-Laaksi1]--[@pone.0020743-Ginde1]. In this study we explore whether seasonal vitamin D changes are by themselves pronounced enough to modulate influenza infection rates. Specifically, observed seasonal changes in vitamin D levels are here used to modulate the probability of infection of individuals within an agent-based model and determine whether a realistic seasonal cycle of influenza infection rates can be simulated.

Methods {#s2}
=======

We compute monthly means and standard deviations of 25(OH)D levels in a sample of individuals enrolled in vitamin D substudies in the Health Professionals Follow-up Study, a prospective investigation of the causes of chronic diseases in male health professionals [@pone.0020743-Giovannucci1]. We include 722 observations from individuals residing in the Great Lakes region and 701 observations from those in the Northeast region whose blood was drawn between the years 1993--1995 ([Table 1](#pone-0020743-t001){ref-type="table"}).

10.1371/journal.pone.0020743.t001

###### 1993--1995 average monthly mean and standard deviation of 25-hydroxy-vitamin D levels for the Great Lakes and Northeast U.S. regions.

![](pone.0020743.t001){#pone-0020743-t001-1}

               Great Lakes   Northeast                        
  ----------- ------------- ----------- ------- ----- ------- -------
  January          25          24.28     8.39    16    25.44   7.52
  February         24          23.05     6.92    23    26.83   9.01
  March            47          25.04     9.49    35    23.77   10.32
  April            31          24.81     6.35    25    23.59   11.78
  May              49          26.60     7.67    57    26.79   9.69
  June             94          28.57     8.45    105   27.99   13.85
  July             78          32.46     11.34   96    29.51   9.17
  August           73          32.14     9.52    85    31.52   9.47
  September        156         32.13     10.74   98    31.63   12.62
  October          68          28.82     10.70   68    28.65   9.83
  November         46          27.94     9.13    60    25.89   9.87
  December         31          26.71     8.34    33    24.26   7.53

The Great Lakes includes the states of Illinois, Indiana, Iowa, Michigan, Minnesota, Montana, and Wisconsin. The Northeast includes the states of Connecticut, Delaware, Maine, Maryland, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, West Virginia, Vermont and the District of Columbia.

We use an agent-based version of the perfectly-mixed SIRS model previously described in Shaman et al. [@pone.0020743-Shaman2], but here adapted for forcing with observed 25(OH)D levels, rather than absolute humidity (AH). Briefly, the 25(OH)D level of each individual, or agent, within the model is tracked explicitly. Each individual is ranked and, based on this percentile, assigned a monthly 25(OH)D level using the 1993--1995 average monthly mean and variance of 25(OH)D levels for the region modeled (e.g. the northeastern U.S.); these average monthly 25(OH)D levels were approximately normally distributed. To allow for additional daily variation among individuals, each person was randomly allowed to drift from their prescribed monthly 25(OH)D percentile by ±0.1% per day.

The 25(OH)D level, *V~i,t~,* of individual *i* on day *t* was then transformed into an adjustment of individual likelihood of infection, *γ~i,t~*, via ([Figure 1](#pone-0020743-g001){ref-type="fig"}):

![κ~i,t~ and γ~i,t~ plotted as a function of 25(OH)D level for various parameter combinations.\
a) *κ* ~i,t~ plotted for different combinations of *λ* and *η*. b) *γ~i,t~* plotted for *λ* = 20 *ng/ml* and *η* = 10 *ng/ml* and different levels of *ϕ*. c) *γ~i,t~* plotted for *λ* = 20 *ng/ml* and *η* = 2 *ng/ml* and different levels of *ϕ*.](pone.0020743.g001){#pone-0020743-g001}

where *κ* ~i,t~ is

*λ* determines the inflection point of the hyberbolic tangent function, *η* modifies the slope through this inflection, and *ϕ* scales *γ~i,t~* to a value between 0 and 1. By defining the inflection point of the hyperbolic tangent function, *λ* sets the \[25(OH)D\] level at which *γ~i,t~* changes most precipitously ([Figure 1](#pone-0020743-g001){ref-type="fig"}). By modifying the slope through the inflection point, *η* delineates whether the change in *γ~i,t~* as 25(OH)D level varies is gradual or more like a step function.

The daily probability that a susceptible individual is infected, *ν~i,t~* is then scaled by this adjustment:where *β* is the transmission rate constant, *I~t~* is the daily number of infectious people, and *N* is the population size. By construct, persons with higher 25(OH)D levels have smaller *γ~i,t~* and reduced risk of infection. For the population as a whole, the daily mean value of *γ~i,t~* modifies the basic reproduction number, *R* ~0~, such that an instantaneous basic reproduction number for the population can be defined as . represents the number of secondary cases a primary case would infect if no one were immune and the distribution of *γ~i,t~* were that observed on day *t.* This instantaneous basic reproduction number accounts for changes in the likelihood of infection due to population mean Vitamin D levels; however, this quantity does not account for susceptibility to influenza, i.e. immune status. The actual mean number of secondary cases per case at a given time is the effective reproductive number, which is approximately and determines whether total cases are increasing or declining in the population. This relation is approximate because it does not take account of the possible correlation between an individual\'s vitamin D status and whether or not s/he is in the immune category. The model accounts for such correlations by modeling transmission (and vitamin D status) at the individual level.

The model includes 6 free parameters and was run in ensembles of 3000 simulations. Parameters *λ* and *η* were fixed for all 3000 runs of an ensemble, but varied between ensembles. The remaining 4 parameters---*ϕ*, *R* ~0~ ^\*^, the value *R* ~0~ would have if *γ~i,t~* equaled one for the entire population, *D*, the mean infectious period, and *L,* the average duration of immunity---were varied among the simulations within an ensemble using a Latin hypercube sampling structure with uniform distribution, as in Shaman et al. [@pone.0020743-Shaman2]. Parameter ranges were: ; ; ; ; *;* . The range of *λ* was assigned to match levels below which parathyroid hormone levels are elevated [@pone.0020743-Cannell1], [@pone.0020743-Lips1]; the ranges of *R* ~0~ ^\*^, *D,* and, *L* match those employed previously for this model [@pone.0020743-Shaman2]; *η* and *ϕ* were varied to consider a wide range of potential responses to higher 25(OH)D levels. *R* ~0~ ^\*^ was allowed to drop below critical levels for some simulations, though these few runs fail to sustain continued influenza transmission; more often *R* ~0~ ^\*^ was prescribed to be above 2, though daily modulation of *R* ~0~ ^\*^ by *γ~i,t~* typically produced instantaneous basic reproduction numbers (*R* ~0*t*~) of much lower magnitude within such simulations.

Each simulation used a population of *N = *100,000 persons and was run for 31 years. The model simulates two influenza virus groupings (A-H3N2 and a grouping of the A-H1N1 and B subtypes) without cross immunity. The quality of each simulation was evaluated based on root mean squared (RMS) error with daily observed 1972--2002 excess pneumonia and influenza (P&I) mortality [@pone.0020743-Simonsen1], [@pone.0020743-Viboud1]. Simulations for the northeast U.S. region were evaluated with New York state excess P&I mortality. Simulations for the Great Lakes region were evaluated with Illinois state excess P&I mortality.

To test the sensitivity of model outcome to stochastic processes we re-ran the 10 best-fitting parameter combinations for certain ensembles. Each of these parameter combinations was run 100 additional times, each time with different random seeding, to examine the role stochasticity had in producing well-matched simulations. An analogous test was performed in Shaman et al. [@pone.0020743-Shaman2] for simulations forced with either AH or the school calendar.

Additionally, to determine whether the vitamin D-forced simulations were corrupted by the coarse monthly temporal resolution of the data, we interpolated the mean and variance of the monthly vitamin D data to daily values using a cubic spline and used these daily-interpolated values to force the influenza model. Simulations were repeated in this fashion for both the Northeast and Great Lakes regions, and the role of stochasticity was also examined, as described above. For these daily interpolated runs individuals were still ranked but were instead assigned a daily 25(OH)D level based on the daily mean and variance.

Vitamin D simulations were also compared with previously-run simulations forced with either AH or the school calendar for New York state and Illinois; the descriptions and parameterizations of these models can be found in Shaman et al. [@pone.0020743-Shaman2]. In addition, new AH-forced simulations were run for both New York state and Illinois in which the 1972--2002 time series of daily AH conditions for each of these states was replaced with 31-year daily average values. This averaging eliminates year-to-year variability from the AH-forcing and provides a more fair comparison with the vitamin D- and school calendar-forced model runs, which also lack year-to-year variability.

Results {#s3}
=======

Best-fitting simulations are presented for the Great Lakes region using and ([Table 2](#pone-0020743-t002){ref-type="table"}) and the northeast U.S. using and ([Table 3](#pone-0020743-t003){ref-type="table"}). Results with other combinations of *λ* and *η,* as well as with forcing using daily interpolated 25(OH)D levels were comparable (not shown). The quality of these simulations in terms of RMS error and correlation with observed P&I mortality is comparable to simulations with the AH and school calendar forced SIRS model (see Tables S2 and S5 in Shaman et al. [@pone.0020743-Shaman2]). Simulated daily average infection rates capture the seasonal cycle of P&I mortality ([Figure 2](#pone-0020743-g002){ref-type="fig"}).

![Best-fitting SIRS model simulation for the northeastern U.S. with parameters λ and η fixed at and .\
Other parameters are shown in the top line of [Table 3](#pone-0020743-t003){ref-type="table"}. The 31-year simulated mean daily infection number has been scaled to the observed 1972--2002 mean daily excess P&I mortality rate for New York state.](pone.0020743.g002){#pone-0020743-g002}
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###### Parameter combinations for the 10 best-fit simulations for the Great Lakes region as validated with Illinois P&I mortality data.
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  Rank    RMS Error   Correlation Coefficient (r)   L (years)   D (days)          ^\*^
  ------ ----------- ----------------------------- ----------- ---------- ------ ------
  1        0.0049                0.93                 5.74        4.58     5.11   2.35
  2        0.0061                0.87                 3.81        2.08     3.33   2.84
  3        0.0062                0.84                 9.78        2.68     4.92   1.90
  4        0.0062                0.86                 3.54        3.60     2.85   3.18
  5        0.0064                0.86                 3.66        3.29     3.67   2.29
  6        0.0064                0.88                 4.39        6.47     7.13   2.69
  7        0.0065                0.83                 7.65        2.42     2.79   3.69
  8        0.0066                0.82                 4.59        2.71     3.30   2.34
  9        0.0069                0.82                 4.81        6.53     3.15   3.32
  10       0.0069                0.91                 7.41        5.80     7.71   2.14

3000 simulations were performed at each site with the parameters *L* (mean duration of immunity), *D* (mean infectious period), *ϕ* (vitamin D scaling), and *R* ~0~ ^\*^ (the basic reproduction number if *γ~i,t~* = 1) randomly chosen from within specified ranges. Parameters *λ* (inflection point) and *η* (inflection point slope) were fixed at and . Best-fit simulations were selected based on RMS error after scaling the 31-year mean daily infection number to the 31-year mean observed daily excess P&I mortality rate.

10.1371/journal.pone.0020743.t003

###### Parameter combinations for the 10 best-fit simulations for the northeastern U.S. as validated with New York state P&I mortality data.

![](pone.0020743.t003){#pone-0020743-t003-3}

  Rank    RMS Error   Correlation Coefficient(r)   L (years)   D (days)          ^\*^
  ------ ----------- ---------------------------- ----------- ---------- ------ ------
  1        0.0070                0.94                5.59        5.69     3.83   2.83
  2        0.0071                0.94                5.64        5.43     4.99   2.48
  3        0.0071                0.90                9.78        5.59     2.43   3.69
  4        0.0072                0.88                9.80        3.59     2.55   3.83
  5        0.0072                0.90                2.53        6.04     2.86   2.44
  6        0.0073                0.89                9.71        3.68     5.54   1.94
  7        0.0074                0.89                3.28        4.31     2.13   3.22
  8        0.0075                0.90                8.73        3.74     6.79   3.02
  9        0.0077                0.91                6.44        5.72     4.24   2.59
  10       0.0077                0.91                6.29        3.17     9.27   1.74

3000 simulations were performed at each site with the parameters *L* (mean duration of immunity), *D* (mean infectious period), *ϕ* (vitamin D scaling), and *R* ~0~ ^\*^ (the basic reproduction number number if *γ~i,t~* = 1) randomly chosen from within specified ranges. Parameters *λ* (inflection point) and *η* (inflection point slope) were fixed at and . Best-fit simulations were selected based on RMS error after scaling the 31-year mean daily infection number to the 31-year mean observed daily excess P&I mortality rate.

Only a portion of the population seasonally crosses the inflection point for *γ~i,t~* as 25(OH)D levels change ([Figure 1b,c](#pone-0020743-g001){ref-type="fig"}) such that only a portion of the population experiences a pronounced modulation of the likelihood of infection. When the slope of *κ* ~i,t~ at its inflection is steep (i.e. *η* small) large portions of the population experience little seasonal change in *γ~i,t~*. Still, the portion that is modulated is sufficient at times to phase peak infection during winter and produce a realistic seasonal cycle.

However, best-fitting model parameter combinations are not consistent among best-fitting runs ([Tables 2](#pone-0020743-t002){ref-type="table"} and [3](#pone-0020743-t003){ref-type="table"}), unlike what has been found for simulations forced with observed absolute humidity. Furthermore, some simulations with similar parameter combinations produce anti-correlated seasonal cycles of influenza infection (). These findings indicate that the quality of fit might be heavily influenced by stochastic events, such that particular parameter combinations could on occasion produce a realistic seasonal cycle, but would not reliably do so. To test this hypothesis, we re-ran the simulations with the top 10 parameter combinations as described in the [Methods](#s2){ref-type="sec"} section. An identical test had previously been performed for SIRS simulations forced with either AH or the school calendar [@pone.0020743-Shaman2] and both these alternate forcing mechanisms prove more resilient to changes in random seeding with AH performing the best ([Figure 3](#pone-0020743-g003){ref-type="fig"}).

![Test of the effect of stochasticity within the SIRS model on well-matched simulations verified with New York state P&I mortality data.\
a) The 10 best-fit parameter combinations for the SIRS model forced with observed New York school calendar (Shaman et al., 2010: Table S5), observed New York absolute humidity (Shaman et al., 2010: Table S2), and northeastern U.S. vitamin D metabolite levels ([Table 3](#pone-0020743-t003){ref-type="table"}) were each run an additional 100 times, each time with different random seeding. Histograms of correlations with 1972--2002 New York state observed excess P&I mortality are shown. The green line indicates the correlation of an optimally phased sine function with annual periodicity with 1972--2002 New York state observed excess P&I mortality (*r* = 0.80). b) As in a), but for the 10 best-fit simulations using 1972--2002 daily average New York absolute humidity and daily interpolated northeastern U.S. vitamin D metabolite levels.](pone.0020743.g003){#pone-0020743-g003}

As a reference, a simple sine function with annual period, if appropriately phased, is highly correlated with the seasonal cycle of observed excess P&I mortality (e.g. *r  = *0.80 for New York state, [Figure 3](#pone-0020743-g003){ref-type="fig"}). One might expect that a credible process-based model of the seasonal influenza cycle would consistently improve on this correlation. However, in comparison to school-term forcing and AH forcing, the re-run top parameter sets for 25(OH)D forcing performed considerably worse, as measured by the Pearson correlation between re-run simulations and observations. Specifically, the additional AH forced simulations are much more consistently matched with observations (mean *r* = 0.912; minimum *r* = 0.670; maximum *r* = 0.981) than the additional school calendar forced simulations (mean *r* = 0.704; minimum *r* = −0.024; maximum *r* = 0.962) or the additional vitamin D forced simulations (mean *r* = 0.490; minimum *r*  =  −0.512; maximum *r* = 0.950) ([Figure 3a](#pone-0020743-g003){ref-type="fig"}). Both the school and vitamin D models, on average, fall below the correlation level of the naïve sine function model.

A similar test of the effect of stochasticity for the model forced with daily-interpolated vitamin D levels was also not consistently well matched with observations (mean *r* = 0.516; minimum *r*  =  −0.550; maximum *r* = 0.965) ([Figure 3b](#pone-0020743-g003){ref-type="fig"}). Conversely, the same test applied to daily-averaged AH-forced simulations was consistently well matched with observations (mean *r* = 0.904; minimum *r* = 0.558; maximum *r* = 0.984). These last two ensembles both use daily forcing without any year-to-year variability, yet the AH-forced model is much more consistently highly correlated with observations than the vitamin D model and on average is better correlated than the naïve sine function model.

Discussion {#s4}
==========

Simulation of the seasonal cycle of influenza infection in regions of the U.S. is possible using an SIRS model forced with observed vitamin D levels. However, secondary evidence casts doubt on the validity of this outcome. Parameter combinations that produce a good seasonal cycle of influenza are not similar to one another, and multiple stochastic runs do not reproduce the seasonal cycle reliably, in contrast to similar runs with the other candidate drivers of seasonality, in particular AH.

Any forcing with a strong seasonal cycle will produce an appropriate seasonal cycle of influenza infection when applied to an SIRS model with an appropriate combination of parameters and stochastic events. For such results to be credible, however, it is necessary that the parameter combinations that produce best-fitting simulations are biologically plausible, approximately consistent from one simulation to another, and are not easily affected by random events within the model. The model presented here fails the latter 2 conditions and therefore suggests that seasonal changes in vitamin D levels are not the predominant determinant of influenza seasonality in temperate regions.

The generalizability of our study may be limited by the fact that vitamin D levels were measured only in male health professionals; nonetheless, the mean 25(OH)D values were similar to those of a nationally representative study population [@pone.0020743-Martins1]. Within the Health Professionals vitamin D dataset used here [@pone.0020743-Giovannucci1], no age-related differences in seasonal vitamin D levels were evident. In the future, should more detailed data representing a broader demography become available in which age-stratified vitamin D effects are evident, these effects could be incorporated and tested within the model framework.

Given that vitamin D affects the immune system [@pone.0020743-Wang1], [@pone.0020743-Liu1], one can hypothesize that severity and duration of influenza infection would also be modulated by vitamin D levels; however, we are unaware of any observational evidence supporting this hypothesis. Should such findings emerge in the future, this evidence would motivate proper testing of vitamin D-induced changes in the severity or duration of infection on the seasonality of influenza. This study was also limited by a lack of detailed *daily* 25(OH)D data; however, 25(OH)D levels are not subject to drastic day-to-day variations so this shortcoming likely did not affect our results.

Previous work indicates that increased solar radiation anomalies are associated with the onset of individual influenza outbreaks [@pone.0020743-Shaman2]. This association between increased sunlight availability and increased influenza transmission is incongruous with the vitamin D hypothesis (i.e. of the wrong sign) and also undermines the notion that vitamin D is a dominant driver of influenza transmission in temperate regions. While it remains possible that low levels of vitamin D could contribute to influenza occurrence, we conclude that present evidence for seasonal variation in serum vitamin D metabolite levels as a driver for influenza seasonality is considerably weaker than that for other proposed mechanisms, in particular seasonal variation in AH and seasonal changes in host aggregation driven by school terms.
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